Published in J Clin Neurosci on May 26, 2010
Comment on "Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke". J Clin Neurosci (2010) 0.75
Low-Dose Versus Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Meta-Analysis. Medicine (Baltimore) (2015) 0.75
A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke. Sci Rep (2016) 0.75
Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial. Stroke Vasc Neurol (2017) 0.75
Clinical implication of hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. Neurol Sci (2016) 0.75
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Stroke. Lancet (2008) 9.51
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust (2003) 4.24
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Current status of pipeline embolization device in the treatment of intracranial aneurysms: a review. World Neurosurg (2012) 2.93
Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol (2002) 2.79
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke (2008) 2.39
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke (2003) 2.25
Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol (2002) 2.25
The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit. Med J Aust (2002) 2.13
Warfarin-associated intracerebral hemorrhage: volume, anticoagulation intensity and location. J Neurol Sci (2013) 2.11
Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology (2012) 2.06
National healthline responses to a stroke scenario: implications for early intervention. Stroke (2007) 2.06
Emergency department workload increase: dependence on primary care? J Emerg Med (2009) 2.04
Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke (2011) 2.03
Low Alberta Stroke Program Early CT score (ASPECTS) associated with malignant middle cerebral artery infarction. Cerebrovasc Dis (2014) 1.99
Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med (2010) 1.97
World Stroke Organization global stroke services guidelines and action plan. Int J Stroke (2014) 1.94
Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis (2010) 1.93
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke (2004) 1.81
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused. Med J Aust (2007) 1.71
Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology (2013) 1.69
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab (2010) 1.68
The physiological significance of the time-to-maximum (Tmax) parameter in perfusion MRI. Stroke (2010) 1.62
Evidence-based care and outcomes of acute stroke managed in hospital specialty units. Med J Aust (2003) 1.61
Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke (2003) 1.59
Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol (2009) 1.59
Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis (2011) 1.53
Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke (2011) 1.52
Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Cerebrovasc Dis (2013) 1.52
Association between early returns and frequent ED visits at a rural academic medical center. Am J Emerg Med (2003) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab (2011) 1.47
Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology (2014) 1.46
Patients with transient ischemic attack or minor stroke should be admitted to hospital: for. Stroke (2006) 1.45
MRI and stroke: why has it taken so long? Lancet (2007) 1.44
Greater effect of stroke thrombolysis in the presence of arterial obstruction. Ann Neurol (2011) 1.44
Ischaemic stroke: the ocular motor system as a sensitive marker for motor and cognitive recovery. J Neurol Neurosurg Psychiatry (2012) 1.43
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke (2012) 1.42
Mismatch-based delayed thrombolysis: a meta-analysis. Stroke (2009) 1.41
When to measure lipid profile after stroke? Cerebrovasc Dis (2005) 1.39
Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke (2014) 1.38
Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab (2013) 1.36
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
Violence in the emergency department: a national survey of emergency medicine residents and attending physicians. J Emerg Med (2010) 1.27
Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke (2009) 1.23
How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol (2011) 1.22
Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke (2012) 1.21
Patent foramen ovale and stroke: closure by further randomized trial is required! Stroke (2004) 1.20
The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke (2010) 1.20
Stroke thrombolysis: save a minute, save a day. Stroke (2014) 1.17
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke (2009) 1.16
Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke (2009) 1.13
Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke. J Stroke Cerebrovasc Dis (2012) 1.12
Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol (2002) 1.11
A comparison of National Emergency Department use by homeless versus non-homeless people in the United States. J Health Care Poor Underserved (2009) 1.09
EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-Registration. Stroke (2010) 1.09
The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci (2002) 1.09
Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke (2004) 1.08
Intracerebral haemorrhage: a need for more data and new research directions. Lancet Neurol (2010) 1.07
Vascular imaging adds value in investigation of basal ganglia hemorrhage. J Clin Neurosci (2011) 1.07
A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA). Int J Stroke (2013) 1.06
Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging. Stroke (2002) 1.05
Stroke: working toward a prioritized world agenda. Stroke (2010) 1.05
Carotid-artery stenting in stroke prevention. N Engl J Med (2010) 1.04
Is hypertension predictive of clinical recurrence in posterior reversible encephalopathy syndrome? J Clin Neurosci (2012) 1.02
Quantity and size distribution of cough-generated aerosol particles produced by influenza patients during and after illness. J Occup Environ Hyg (2012) 1.02
Antiplatelet resistance and thromboembolic complications in neurointerventional procedures. Front Neurol (2011) 1.01
Stroke: working toward a prioritized world agenda. Cerebrovasc Dis (2010) 1.01
Application of different methods for nuclear shape analysis with special reference to the differentiation of brain tumors. Anal Quant Cytol Histol (2006) 1.01
Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data. Stroke (2006) 1.00
Neurologist, internist, or strokologist? Stroke (2003) 1.00
Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke (2009) 1.00
Assessing response to stroke thrombolysis: validation of 24-hour multimodal magnetic resonance imaging. Arch Neurol (2011) 0.99
Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage. Stroke (2008) 0.99
Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial. Stroke (2006) 0.99
Validation of the DRAGON score in 12 stroke centers in anterior and posterior circulation. Stroke (2013) 0.98
Multicenter comparison of processes of care between Stroke Units and conventional care wards in Australia. Stroke (2004) 0.98
Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke (2007) 0.97
Endovascular treatment for acute ischemic stroke. N Engl J Med (2013) 0.97
Moving beyond a single perfusion threshold to define penumbra: a novel probabilistic mismatch definition. Stroke (2012) 0.97
The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study. Stroke (2012) 0.96
Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann Neurol (2013) 0.95
Imaging selection in ischemic stroke: feasibility of automated CT-perfusion analysis. Int J Stroke (2014) 0.94
A topographic study of the evolution of the MR DWI/PWI mismatch pattern and its clinical impact: a study by the EPITHET and DEFUSE Investigators. Stroke (2011) 0.94